Skip to main content
Erschienen in: Annals of Surgical Oncology 9/2020

09.05.2020 | Hepatobiliary Tumors

Assessing Textbook Outcomes Following Liver Surgery for Primary Liver Cancer Over a 12-Year Time Period at Major Hepatobiliary Centers

verfasst von: Diamantis I. Tsilimigras, MD, Kota Sahara, MD, Dimitrios Moris, MD, PhD, Rittal Mehta, MPH, BDS, Anghela Z. Paredes, MD, MS, Francesca Ratti, MD, Hugo P. Marques, MD, Olivier Soubrane, MD, Vincent Lam, MD, George A. Poultsides, MD, Irinel Popescu, MD, Sorin Alexandrescu, MD, Guillaume Martel, MD, Aklile Workneh, MD, Alfredo Guglielmi, MD, Tom Hugh, MD, Luca Aldrighetti, MD, Matthew Weiss, MD, Todd W. Bauer, MD, Shishir K. Maithel, MD, Carlo Pulitano, MD, Feng Shen, MD, Bas Groot Koerkamp, MD, Itaru Endo, MD, PhD, Timothy M. Pawlik, MD, MPH, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 9/2020

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The objective of the current study was to comprehensively assess the change of practice in hepatobiliary surgery by determining the rates and the trends of textbook outcomes (TO) among patients undergoing surgery for primary liver cancer over time.

Methods

Patients undergoing curative-intent resection for primary liver malignancies, including hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) between 2005 and 2017 were analyzed using a large, international multi-institutional dataset. Rates of TO were assessed over time. Factors associated with achieving a TO and the impact of TO on long-term survival were examined.

Results

Among 1829 patients, 944 (51.6%) and 885 (48.4%) individuals underwent curative-intent resection for HCC and ICC, respectively. Over time, patients were older, more frequently had ASA class > 2, albumin-bilirubin grade 2/3, major vascular invasion and more frequently underwent major liver resection (all p < 0.05). Overall, a total of 1126 (62.0%) patients achieved a TO. No increasing trends in TO rates were noted over the years (ptrend = 0.90). In addition, there was no increasing trend in the TO rates among patients undergoing either major (ptrend = 0.39) or minor liver resection (ptrend = 0.63) over the study period. Achieving a TO was independently associated with 26% and 37% decreased hazards of death among ICC (HR 0.74, 95%CI 0.56–0.97) and HCC patients (HR 0.63, 95%CI 0.46–0.85), respectively.

Conclusion

Approximately 6 in 10 patients undergoing surgery for primary liver tumors achieved a TO. While TO rates did not increase over time, TO was associated with better long-term outcomes following liver resection for both HCC and ICC.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.CrossRefPubMed Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.CrossRefPubMed
2.
Zurück zum Zitat Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.PubMedCrossRef Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.PubMedCrossRef
3.
Zurück zum Zitat Liu Z, Jiang Y, Yuan H, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the global burden of disease study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70(4):674–83.PubMedCrossRef Liu Z, Jiang Y, Yuan H, et al. The trends in incidence of primary liver cancer caused by specific etiologies: results from the global burden of disease study 2016 and implications for liver cancer prevention. J Hepatol. 2019;70(4):674–83.PubMedCrossRef
4.
Zurück zum Zitat Petrick JL, Kelly SP, Altekruse SF, McGlynn KA, Rosenberg PS. Future of hepatocellular carcinoma incidence in the united states forecast through 2030. J Clin Oncol. 2016;34(15):1787–94.PubMedPubMedCentralCrossRef Petrick JL, Kelly SP, Altekruse SF, McGlynn KA, Rosenberg PS. Future of hepatocellular carcinoma incidence in the united states forecast through 2030. J Clin Oncol. 2016;34(15):1787–94.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Tsilimigras DI, Bagante F, Sahara K, et al. Prognosis after resection of barcelona clinic liver cancer (BCLC) stage 0, A, and B hepatocellular carcinoma: a comprehensive assessment of the current BCLC classification. Ann Surg Oncol. 2019;26(11):3693–700.PubMedCrossRef Tsilimigras DI, Bagante F, Sahara K, et al. Prognosis after resection of barcelona clinic liver cancer (BCLC) stage 0, A, and B hepatocellular carcinoma: a comprehensive assessment of the current BCLC classification. Ann Surg Oncol. 2019;26(11):3693–700.PubMedCrossRef
6.
Zurück zum Zitat Dimick JB, Staiger DO, Baser O, Birkmeyer JD. Composite measures for predicting surgical mortality in the hospital. Health Aff (Millwood). 2009;28(4):1189–98.CrossRef Dimick JB, Staiger DO, Baser O, Birkmeyer JD. Composite measures for predicting surgical mortality in the hospital. Health Aff (Millwood). 2009;28(4):1189–98.CrossRef
7.
Zurück zum Zitat Dimick JB, Birkmeyer NJ, Finks JF, et al. Composite measures for profiling hospitals on bariatric surgery performance. JAMA Surg. 2014;149(1):10–6.PubMedPubMedCentralCrossRef Dimick JB, Birkmeyer NJ, Finks JF, et al. Composite measures for profiling hospitals on bariatric surgery performance. JAMA Surg. 2014;149(1):10–6.PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Dimick JB, Staiger DO, Osborne NH, Nicholas LH, Birkmeyer JD. Composite measures for rating hospital quality with major surgery. Health Serv Res. 2012;47(5):1861–79.PubMedPubMedCentralCrossRef Dimick JB, Staiger DO, Osborne NH, Nicholas LH, Birkmeyer JD. Composite measures for rating hospital quality with major surgery. Health Serv Res. 2012;47(5):1861–79.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Staiger DO, Dimick JB, Baser O, Fan Z, Birkmeyer JD. Empirically derived composite measures of surgical performance. Med Care. 2009;47(2):226–33.PubMedCrossRef Staiger DO, Dimick JB, Baser O, Fan Z, Birkmeyer JD. Empirically derived composite measures of surgical performance. Med Care. 2009;47(2):226–33.PubMedCrossRef
11.
Zurück zum Zitat Merath K, Chen Q, Bagante F, et al. A multi-institutional international analysis of textbook outcomes among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma. JAMA Surg. 2019;154:e190571.PubMedPubMedCentralCrossRef Merath K, Chen Q, Bagante F, et al. A multi-institutional international analysis of textbook outcomes among patients undergoing curative-intent resection of intrahepatic cholangiocarcinoma. JAMA Surg. 2019;154:e190571.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat van Roessel S, Mackay TM, van Dieren S, et al. Textbook outcome: nationwide analysis of a novel quality measure in pancreatic surgery. Ann Surg. 2019;271:155–62.CrossRef van Roessel S, Mackay TM, van Dieren S, et al. Textbook outcome: nationwide analysis of a novel quality measure in pancreatic surgery. Ann Surg. 2019;271:155–62.CrossRef
13.
Zurück zum Zitat Wu L, Tsilimigras DI, Paredes AZ, et al. Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy and overall survival. World J Surg. 2019;43(7):1777–87.PubMedCrossRef Wu L, Tsilimigras DI, Paredes AZ, et al. Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy and overall survival. World J Surg. 2019;43(7):1777–87.PubMedCrossRef
14.
Zurück zum Zitat Tsilimigras DI, Sahara K, Moris D, et al. Effect of surgical margin width on patterns of recurrence among patients undergoing R0 hepatectomy for T1 hepatocellular carcinoma: an international multi-institutional analysis. J Gastrointest Surg. 2019. https://doi.org/10.1007/s11605-019-04275-0. Tsilimigras DI, Sahara K, Moris D, et al. Effect of surgical margin width on patterns of recurrence among patients undergoing R0 hepatectomy for T1 hepatocellular carcinoma: an international multi-institutional analysis. J Gastrointest Surg. 2019. https://​doi.​org/​10.​1007/​s11605-019-04275-0.
15.
Zurück zum Zitat Tsilimigras DI, Hyer JM, Moris D, et al. Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: a multi-institutional analysis of 706 patients. J Surg Oncol. 2019;120(2):206–13.PubMed Tsilimigras DI, Hyer JM, Moris D, et al. Prognostic utility of albumin-bilirubin grade for short- and long-term outcomes following hepatic resection for intrahepatic cholangiocarcinoma: a multi-institutional analysis of 706 patients. J Surg Oncol. 2019;120(2):206–13.PubMed
16.
Zurück zum Zitat Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg. 2005;12(5):351–5.PubMedCrossRef Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg. 2005;12(5):351–5.PubMedCrossRef
17.
Zurück zum Zitat Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–9.PubMedCrossRef Amin MB, Greene FL, Edge SB, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017;67(2):93–9.PubMedCrossRef
18.
Zurück zum Zitat Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96.CrossRefPubMed Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250(2):187–96.CrossRefPubMed
19.
Zurück zum Zitat Luu C, Goldstein L, Goldner B, Schoellhammer HF, Chen SL. Trends in radiotherapy after breast-conserving surgery in elderly patients with early-stage breast cancer. Ann Surg Oncol. 2013;20(10):3266–73.PubMedCrossRef Luu C, Goldstein L, Goldner B, Schoellhammer HF, Chen SL. Trends in radiotherapy after breast-conserving surgery in elderly patients with early-stage breast cancer. Ann Surg Oncol. 2013;20(10):3266–73.PubMedCrossRef
20.
Zurück zum Zitat Virani S, Michaelson JS, Hutter MM, et al. Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg. 2007;204(6):1284–92.PubMedCrossRef Virani S, Michaelson JS, Hutter MM, et al. Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg. 2007;204(6):1284–92.PubMedCrossRef
21.
Zurück zum Zitat Spolverato G, Yakoob MY, Kim Y, et al. Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinoma. Cancer. 15 2015;121(16):2730–9.PubMedCrossRef Spolverato G, Yakoob MY, Kim Y, et al. Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinoma. Cancer. 15 2015;121(16):2730–9.PubMedCrossRef
22.
Zurück zum Zitat Tsilimigras DI, Mehta R, Moris D, et al. Utilizing machine learning for pre- and postoperative assessment of patients undergoing resection for BCLC-0, A and B hepatocellular carcinoma: implications for resection beyond the BCLC guidelines. Ann Surg Oncol. 2019;27:866–74PubMedCrossRef Tsilimigras DI, Mehta R, Moris D, et al. Utilizing machine learning for pre- and postoperative assessment of patients undergoing resection for BCLC-0, A and B hepatocellular carcinoma: implications for resection beyond the BCLC guidelines. Ann Surg Oncol. 2019;27:866–74PubMedCrossRef
23.
Zurück zum Zitat Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247(1):49–57.PubMedCrossRef Abulkhir A, Limongelli P, Healey AJ, et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg. 2008;247(1):49–57.PubMedCrossRef
24.
Zurück zum Zitat Cloyd JM, Mizuno T, Kawaguchi Y, et al. Comprehensive complication index validates improved outcomes over time despite increased complexity in 3707 consecutive hepatectomies. Ann Surg. 2020;271(4):724-731. Cloyd JM, Mizuno T, Kawaguchi Y, et al. Comprehensive complication index validates improved outcomes over time despite increased complexity in 3707 consecutive hepatectomies. Ann Surg. 2020;271(4):724-731.
25.
Zurück zum Zitat Kokudo T, Hasegawa K, Matsuyama Y, et al. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. J Hepatol. 2016;65(5):938–43.PubMedCrossRef Kokudo T, Hasegawa K, Matsuyama Y, et al. Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion. J Hepatol. 2016;65(5):938–43.PubMedCrossRef
26.
Zurück zum Zitat Neuwirth MG, Bierema C, Sinnamon AJ, et al. Trends in major upper abdominal surgery for cancer in octogenarians: has there been a change in patient selection? Cancer. 2018;124(1):125–35.PubMedCrossRef Neuwirth MG, Bierema C, Sinnamon AJ, et al. Trends in major upper abdominal surgery for cancer in octogenarians: has there been a change in patient selection? Cancer. 2018;124(1):125–35.PubMedCrossRef
27.
Zurück zum Zitat Busweiler LA, Schouwenburg MG, van Berge Henegouwen MI, et al. Textbook outcome as a composite measure in oesophagogastric cancer surgery. Br J Surg. 2017;104(6):742–50.PubMedCrossRef Busweiler LA, Schouwenburg MG, van Berge Henegouwen MI, et al. Textbook outcome as a composite measure in oesophagogastric cancer surgery. Br J Surg. 2017;104(6):742–50.PubMedCrossRef
28.
Zurück zum Zitat Kolfschoten NE, Kievit J, Gooiker GA, et al. Focusing on desired outcomes of care after colon cancer resections; hospital variations in ‘textbook outcome’. Eur J Surg Oncol. 2013;39(2):156–63.PubMedCrossRef Kolfschoten NE, Kievit J, Gooiker GA, et al. Focusing on desired outcomes of care after colon cancer resections; hospital variations in ‘textbook outcome’. Eur J Surg Oncol. 2013;39(2):156–63.PubMedCrossRef
29.
Zurück zum Zitat Karthaus EG, Lijftogt N, Busweiler LAD, et al. Textbook outcome: a composite measure for quality of elective aneurysm surgery. Ann Surg. 2017;266(5):898–904.PubMedCrossRef Karthaus EG, Lijftogt N, Busweiler LAD, et al. Textbook outcome: a composite measure for quality of elective aneurysm surgery. Ann Surg. 2017;266(5):898–904.PubMedCrossRef
30.
Zurück zum Zitat Liu J, Reid J, Leopardi L, Edwards S, Trochsler M, Maddern G. Progress towards near-zero 90-day mortality: 388 consecutive hepatectomies over a 16-year period. ANZ J Surg. 2019;89(9):1144–7.PubMedCrossRef Liu J, Reid J, Leopardi L, Edwards S, Trochsler M, Maddern G. Progress towards near-zero 90-day mortality: 388 consecutive hepatectomies over a 16-year period. ANZ J Surg. 2019;89(9):1144–7.PubMedCrossRef
31.
Zurück zum Zitat Chan J, Bradshaw L, Houli N, et al. Outcomes of central hepatectomy versus extended hepatectomy. Hepatobiliary Pancreat Dis Int. 2019;18(3):249–54.PubMedCrossRef Chan J, Bradshaw L, Houli N, et al. Outcomes of central hepatectomy versus extended hepatectomy. Hepatobiliary Pancreat Dis Int. 2019;18(3):249–54.PubMedCrossRef
32.
Zurück zum Zitat Beal EW, Tumin D, Kabir A, et al. Trends in the mortality of hepatocellular carcinoma in the United States. J Gastrointest Surg. 2017;21(12):2033–8.PubMedCrossRef Beal EW, Tumin D, Kabir A, et al. Trends in the mortality of hepatocellular carcinoma in the United States. J Gastrointest Surg. 2017;21(12):2033–8.PubMedCrossRef
33.
Zurück zum Zitat Sasaki A, Aramaki M, Kawano K, et al. Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg. 1998;85(9):1206–9.PubMedCrossRef Sasaki A, Aramaki M, Kawano K, et al. Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg. 1998;85(9):1206–9.PubMedCrossRef
34.
Zurück zum Zitat Buettner S, van Vugt JL, JN IJ, Groot Koerkamp B. Intrahepatic cholangiocarcinoma: current perspectives. OncoTargets Ther. 2017;10:1131–42. Buettner S, van Vugt JL, JN IJ, Groot Koerkamp B. Intrahepatic cholangiocarcinoma: current perspectives. OncoTargets Ther. 2017;10:1131–42.
35.
Zurück zum Zitat Chung YE, Kim MJ, Park YN, et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics. 2009;29(3):683–700.PubMedCrossRef Chung YE, Kim MJ, Park YN, et al. Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. Radiographics. 2009;29(3):683–700.PubMedCrossRef
36.
Zurück zum Zitat Idrees JJ, Merath K, Gani F, et al. Trends in centralization of surgical care and compliance with National Cancer Center Network guidelines for resected cholangiocarcinoma. HPB (Oxford). 2019;21(8):981–9.CrossRef Idrees JJ, Merath K, Gani F, et al. Trends in centralization of surgical care and compliance with National Cancer Center Network guidelines for resected cholangiocarcinoma. HPB (Oxford). 2019;21(8):981–9.CrossRef
Metadaten
Titel
Assessing Textbook Outcomes Following Liver Surgery for Primary Liver Cancer Over a 12-Year Time Period at Major Hepatobiliary Centers
verfasst von
Diamantis I. Tsilimigras, MD
Kota Sahara, MD
Dimitrios Moris, MD, PhD
Rittal Mehta, MPH, BDS
Anghela Z. Paredes, MD, MS
Francesca Ratti, MD
Hugo P. Marques, MD
Olivier Soubrane, MD
Vincent Lam, MD
George A. Poultsides, MD
Irinel Popescu, MD
Sorin Alexandrescu, MD
Guillaume Martel, MD
Aklile Workneh, MD
Alfredo Guglielmi, MD
Tom Hugh, MD
Luca Aldrighetti, MD
Matthew Weiss, MD
Todd W. Bauer, MD
Shishir K. Maithel, MD
Carlo Pulitano, MD
Feng Shen, MD
Bas Groot Koerkamp, MD
Itaru Endo, MD, PhD
Timothy M. Pawlik, MD, MPH, PhD
Publikationsdatum
09.05.2020
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 9/2020
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08548-w

Weitere Artikel der Ausgabe 9/2020

Annals of Surgical Oncology 9/2020 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.